-
Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis
Augustijn, Q. J. J., Grefhorst, A., de Groen, P., Wortelboer, K., Seegers, J. F. M. L., Gül, I. S., Suenaert, P., Verheij, J., de Vos, W. M., Herrema, H., Nieuwdorp, M. & Holleboom, A. G., 9 Jan 2025, In: BMJ open. 15, 1, e088290.Research output: Contribution to journal › Article* › Academic › peer-review
-
The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
Heymann, C. J. F., Mak, A. L., Holleboom, A. G., Verheij, J., Shiri-Sverdlov, R., van Mil, S. W. C., Tushuizen, M. E., Koek, G. H. & Grefhorst, A., 1 Dec 2024, In: Lipids in health and disease. 23, 1, 402.Research output: Contribution to journal › Article* › Academic › peer-review
-
Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study
Oostveen, R. F., Kaiser, Y., Hartgers, M. L., Meessen, E. C. E., Grefhorst, A., Hovingh, G. K., Kuipers, F., Stroes, E. S. G., Groen, A. K. & Reeskamp, L. F., 15 Oct 2024, In: Journal of the American Heart Association. 13, 20, p. e035259 e035259.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
